McKesson CEO to retire in 2019

John Hammergren, who has served as the corporate’s CEO for just about 20 years, will retire subsequent yr, and COO Brian Tyler will take his position. Supply...

What CMS’ digital care strikes imply for healthcare at massive

In a telephone interview, Matt Fisher, a spouse with Mirick O’Connell, mentioned CMS’ newest movements relating to digital care are advisable however famous medical doctors shouldn’t omit...

FDA AdCom smacks down Alkermes antidepressant drug, making approval not going

Briefing paperwork from the Psychopharmacologic Medication Advisory Committee previous this week had forged doubt at the probabilities of a favorable vote. Supply hyperlink

Illumina to shop for Pacific Biosciences for $1.2 billion

The $eight in keeping with proportion deal will permit Illumina to faucet into the long-read sequencing marketplace, whilst additionally fending off pageant from different companies, analyst...

CMS will duvet digital maintain the primary time

Medicare can pay for sure verbal exchange technology-based products and services, the faraway analysis of recorded video and/or photographs and an expanded listing of telehealth products...

Gauss Surgical ratings $20M to spice up adoption of blood loss tracking platform

The corporate may even use the Sequence C investment from Northwell Well being, SoftBank Ventures Korea and others to increase new AI-driven packages for the working...

2018 ASH assembly to characteristic new CAR-T treatments for myeloma

Bispecific antibodies like Amgen’s AMG 420 may just provide some festival to CAR-Ts. However may just sequential use of the treatments – which goal the similar...

Sensible tablet bottle writer AdhereTech secures strategic funding from Argentum

The corporate will use the cash to extend its pharmaceutical and pharmacy partnerships, increase into extra healthcare verticals and fortify its knowledge research and engineering packages. Supply...

Gilead Sciences, Tango Therapeutics sign up for forces on immuno-oncology

Tango Therapeutics – which makes use of CRISPR-based screening to search out drug applicants – will obtain $50 million prematurely and be eligible for as much...

Precision drugs approach no one is solely ‘reasonable’

Prostate most cancers survivor Bryce Olson says genomic sequencing presentations the way in which ahead in most cancers remedy, fairly than the one-size-fits-all manner. Supply hyperlink

Must Read